Oslo Economics have presented their ongoing study on myasthenia gravis in the U.S. and Denmark
10.10.2022 - Health and life science
Oslo Economics, UCB Pharma and the University of Bergen are currently collaborating on a research project about the societal costs of myasthenia in Norway. Christoffer Bugge and Ingrid Engebretsen from Oslo Economics have presented preliminary results from the research project on two different conferences. On September 21st ., Christoffer Bugge and Ingrid Engebretsen presented the study at the yearly conference held by the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) in Nashville, Tennessee. On October 1st , Ingrid presented the study at the “Living with Myasthenia gravis”-conference in Denmark. The study is financed by UCB Pharma.
We collect unidentifiable information about visitors to osloeconomics.no to compile statistics, so that we can create a user-friendly website. We can not trace your information back to the individual user.
We collect unidentifiable information about visitors to osloeconomics.no to compile statistics, so that we can create a user-friendly website. We can not trace your information back to the individual user. All data is anonymized and merged, and is not processed individually.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
